NavioMD review
A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
NavioMD at a glance
- Semaglutide
- Ozempic® from $345/mo
- Tirzepatide
- Compounded from $189/mo
- Coverage
- 48 states (not AL or MS)
- Start
- Same day (instant provider match, per the site)
How we scored NavioMD
Each factor is scored from NavioMD's real pricing, disclosures and intake flow, then combined into the 61/100 Rx-Readiness Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Same-day, instant provider access is a specific, verifiable claim — one of the faster stated timelines in this round.
Real starting prices are published for all four options, but 'as low as' tiered-by-dose language means the entry price isn't the full picture.
Framed around 'meet with a provider instantly,' which leans toward a live rather than async intake — scored down from the neutral default.
48 of 50 states, with the 2 gaps (AL, MS) explicitly named.
Tirzepatide is available compounded, but semaglutide is brand-only (Ozempic) — not a genuine both-molecules-compounded menu.
No detailed cancellation policy was itemized on the pages checked.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- naviomd.com
Sourced from WLR's provider directory, independently re-verified live on naviomd.com (2026-08-03). All four tiered starting prices (compounded tirzepatide, Ozempic, Zepbound, Mounjaro) confirmed directly on the homepage pricing grid, matching WLR's recorded figures. The 48-state coverage (excluding AL, MS) confirmed via the site's own FAQ. Named pharmacy partner (The Pharmacy Hub) also confirmed via FAQ.
What to expect when you sign up
We walked NavioMD's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage leads with 'Meet with a provider instantly' and a tiered pricing grid for both compounded tirzepatide and brand-name Ozempic/Zepbound/Mounjaro
- 2Also offers a women's-hormone menu (progesterone capsules, Biest) alongside weight loss, on the same site
- 3FAQ names its exclusive pharmacy partner directly — The Pharmacy Hub — for both compounded and branded medication fulfillment
- 4States operation in 48 states, explicitly excluding Alabama and Mississippi, with automatic eligibility verification during intake
What we noticed
- No compounded semaglutide option was found on this site — readers wanting semaglutide specifically would need to go the brand-name Ozempic route at a meaningfully higher price ($345/mo vs $189/mo for compounded tirzepatide)
- Same-day provider access is a genuine claim — 'available instantly from the hours of 9am-10pm EST'
- Names its pharmacy partner directly (The Pharmacy Hub), a real transparency plus
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS, despite the site's parallel women's-hormone menu
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded tirzepatide | $189 | As low as, tiered by doseListed as 'as low as $189/month'; no compounded semaglutide option was found — semaglutide is only offered as brand-name Ozempic on this site. |
| Brand semaglutide | $345 | Ozempic®, as low as, tiered by doseListed as 'as low as $345/month.' |
| Brand tirzepatide | $445 | Zepbound®, as low as, tiered by doseListed as 'as low as $445/month.' |
| Brand tirzepatide | $1249 | Mounjaro®, as low as, tiered by doseListed as 'as low as $1,249/month' — Mounjaro is tirzepatide's diabetes-indication brand name, listed separately from Zepbound (the weight-loss-indication brand of the same molecule) at a much higher price point. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect NavioMD's public disclosures at last review and change often; confirm the current number on NavioMD's own site.
What we like
- Same-day, instant provider access, per the site — one of the faster claimed timelines in this round
- Names its exclusive pharmacy partner (The Pharmacy Hub) directly
- Offers brand-name Ozempic®, Zepbound®, and Mounjaro® alongside compounded tirzepatide
- Parallel women's-hormone menu (progesterone, Biest) on the same platform
The caveats
- No compounded semaglutide option — semaglutide is only available as brand-name Ozempic at a much higher price
- Not available in Alabama or Mississippi
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS, despite the parallel women's-hormone menu
- No published statement on whether a video visit is required
NavioMD for working moms: our verdict
A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo. It runs about $189/month — a premium to the category, so the extras have to earn it.
We weigh NavioMD the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic weight-loss review skips.
What NavioMD actually costs
- Compounded tirzepatide — As low as, tiered by dose: $189/mo
- Brand-name semaglutide — Ozempic®, as low as, tiered by dose: $345/mo
- Brand-name tirzepatide — Zepbound®, as low as, tiered by dose: $445/mo
- Brand-name tirzepatide — Mounjaro®, as low as, tiered by dose: $1249/mo
For context, the typical ongoing price across our roster is around $150/month, so NavioMD sits at the premium end.
The medications NavioMD prescribes
NavioMD prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters because you can switch between them without re-enrolling or hunting for a new provider mid-plan. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own labeling, though the brand price runs well above the compounded tiers.
Where NavioMD fits — and where it doesn't — for working moms
A good fit if…
- you want to start fast and async — no scheduled video visit to wedge between work and pickup.
Look elsewhere if…
- you'd rather the most predictable place to start and pause — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
NavioMD is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Working moms open to tirzepatide specifically, or comfortable paying brand-name pricing for semaglutide, who want to talk to a provider the same day rather than wait for async review.
Alternatives to NavioMD
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- Visit Telos RxRx-Readiness86100
A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.
Keep comparing NavioMD
Head-to-head & alternatives
NavioMD, answered
- How much does NavioMD cost?
- As last verified, NavioMD's compounded pricing starts around $189/month (Ozempic® from $345/mo semaglutide, Compounded from $189/mo tirzepatide). Confirm the current, all-in price on NavioMD's own site before you commit.
- Can I start NavioMD without a scheduled video visit?
- NavioMD involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does NavioMD offer both semaglutide and tirzepatide?
- Yes — NavioMD offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does NavioMD rank for working moms?
- NavioMD scores 61/100 on our Rx-Readiness Score (rank #48), which weights six factors led by speed to first dose and flat pricing. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect NavioMD's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.